fosun pharma completed the repurchase of shares on November 1, 2024. According to the rules of listing on the main board of the Hong Kong stock exchange, the company repurchased 330,000 common shares on November 1, 2024, at a repurchase price ranging from HKD 14.8 to HKD 14.98 per share, with a total payment of HKD 4,923,171. After the repurchase, the company's issued shares decreased to 546,139,000 shares, while the treasury shares increased to 5,801,500 shares. This repurchase was carried out based on the repurchase authorization obtained on June 26, 2024, and the repurchased shares will be held as treasury shares. According to the rules, the company shall not issue any new shares or further sell or transfer treasury shares within 30 days after the share repurchase, up to December 1, 2024.

fosun pharma completed the repurchase of shares on November 1, 2024. According to the rules of listing on the main board of the Hong Kong stock exchange, the company repurchased 330,000 common shares on November 1, 2024, at a repurchase price ranging from HKD 14.8 to HKD 14.98 per share, with a total payment of HKD 4,923,171. After the repurchase, the company's issued shares decreased to 546,139,000 shares, while the treasury shares increased to 5,801,500 shares. This repurchase was carried out based on the repurchase authorization obtained on June 26, 2024, and the repurchased shares will be held as treasury shares. According to the rules, the company shall not issue any new shares or further sell or transfer treasury shares within 30 days after the share repurchase, up to December 1, 2024.